Galenica Sante AG (GALE.SW) — chart, structure and Closelook read

Pick a ticker to load its detail page.

Company snapshot — Galenica Sante AG

GALE.SW in five paragraphs: what it makes and sells, where it sits in the Closelook stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Galenica Sante runs two businesses in Swiss healthcare: retail pharmacies and pharmacy services under brands such as Amavita, Sun Store and Coop Vitality, plus specialty and home-medication services and diagnostic testing; and a logistics and IT arm that stores, distributes and manages data for pharmaceutical and healthcare firms and supplies pharmacies, doctors and care homes. It is headquartered in Bern and was founded in 1927.
Where it sits in the stack
Galenica sits outside our AI build-out index; it belongs to the healthcare and medical-distribution sleeve of our wider universe, covering retail pharmacy and pharmaceutical logistics rather than compute, chips or data-centre infrastructure.
Who it is priced against
Closelook has not built a peer group for this name; the comparison the market sometimes draws is with Zur Rose Group, the other large Swiss pharmacy and distribution operator.
Why Closelook tracks it
Galenica holds no seat in our indices and carries no Closelook score yet; the diary has not quoted it in an edition.
What the diary watches
The diary watches how the balance between the pharmacy-and-care business and the logistics-and-IT business shifts, since the two segments serve different parts of the Swiss healthcare chain.

Galenica Sante AG (GALE.SW) trades on the SW exchange in Switzerland, classified under Healthcare.

The Closelook company score reads 43/100 composite (momentum 30, quality 28, valuation 65) across 7 modules — the full breakdown, chart structure and analog history load live above.

Written from the company’s public profile and Closelook’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Signals for this name

Every Closelook reading that exists for GALE.SW, from the same nightly bakes the boards use. Research diary readings, not advice.

Who it is priced against Healthcare · Switzerland · 5 names with week and year-to-date

Peer group

Healthcare · Switzerland

Scored names in the same sector and country from the Closelook universe.

Compared against GALE.SW on the nightly bakes; the Peers tab ranks the cohort on the Closelook scores where it exists.

Weather around the name 4 macro readings: Money Temperature, Factor regime, Sector × region …

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 55/100 · S&P 500 fund at 58, above its 50- and 200-day averagesEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-17
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 94th percentile of the window, +2.7% over 20 sessions. Factor regime → 2026-09-17
  • Sector × region Health care in Europe: +1.1% week · −3.6% month · +0.3% quarter · −6.5% yearThe Sector Engine cell this name lives in, from EXV4.XETRA; the 11 × 4 matrix shows where its sector is being bought and where it is being sold. Sector Engine → 2026-09-16
  • Sovereign pressure Index 0.00 · down 0.41 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-17

FAQ · from the current data · as of 2026-09-18

Quick answers

What is Galenica Sante AG (GALE.SW)?

Galenica Sante AG trades as GALE.SW on the SW exchange (Switzerland) and is classified under Healthcare in the Closelook research universe, as of the registry build of 2026-09-18.

Is GALE.SW in a Closelook index?

Not currently — Galenica Sante AG is tracked in the Closelook research universe but is not a constituent of a Closelook functional index as of 2026-09-18.

What is Galenica Sante AG's Closelook composite score?

43 out of 100, with momentum 30, quality 28 and valuation 65 sub-scores, as of 2026-09-18. Scores are Closelook's own research readings, not ratings or investment advice.

Where does GALE.SW trade against its moving averages?

Downtrend stack: Trades -1.7% vs the 50-day and -6.6% vs the 200-day average, 18.4% below the 52-week high and +3.2% off the 52-week low. Computed from daily closes. As of 2026-09-17 — a technical state from the nightly Closelook bake, not advice. The Technical tab carries the full row.

What does Galenica Sante AG do?

Galenica Sante runs two businesses in Swiss healthcare: retail pharmacies and pharmacy services under brands such as Amavita, Sun Store and Coop Vitality, plus specialty and home-medication services and diagnostic testing; and a logistics and IT arm that stores, distributes and manages data for pharmaceutical and healthcare firms and supplies pharmacies, doctors and care homes. It is headquartered in Bern and was founded in 1927. Closelook has not built a peer group for this name; the comparison the market sometimes draws is with Zur Rose Group, the other large Swiss pharmacy and distribution operator.

Where does Galenica Sante AG sit in the AI build-out?

Galenica sits outside our AI build-out index; it belongs to the healthcare and medical-distribution sleeve of our wider universe, covering retail pharmacy and pharmaceutical logistics rather than compute, chips or data-centre infrastructure. Galenica holds no seat in our indices and carries no Closelook score yet; the diary has not quoted it in an edition.

What does this page show?

A live price chart with SMA overlays and drawing tools for GALE.SW, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Related in the Closelook universe